[
  {
    "ts": null,
    "headline": "Lantheus Holdings (LNTH) Is Up 5.2% After Truist Upgrade Highlighting Underappreciated Profit Potential – Has The Bull Case Changed?",
    "summary": "Earlier this month, radiopharmaceutical company Lantheus Holdings received an upgrade from Truist Securities to “Buy,” with the firm highlighting stronger growth and profitability potential from late 2026 onward. This upgrade adds to a generally positive analyst backdrop for Lantheus, with many firms citing the company’s solid financial profile and competitive operating margins as underappreciated strengths. We’ll now explore how Truist’s more optimistic view of Lantheus’s long-term growth...",
    "url": "https://finnhub.io/api/news?id=1da1f419922f321e3eb042cb92a932145e60e5cab3a6dd8333f43a0f45338161",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765671256,
      "headline": "Lantheus Holdings (LNTH) Is Up 5.2% After Truist Upgrade Highlighting Underappreciated Profit Potential – Has The Bull Case Changed?",
      "id": 137780766,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TFC",
      "source": "Yahoo",
      "summary": "Earlier this month, radiopharmaceutical company Lantheus Holdings received an upgrade from Truist Securities to “Buy,” with the firm highlighting stronger growth and profitability potential from late 2026 onward. This upgrade adds to a generally positive analyst backdrop for Lantheus, with many firms citing the company’s solid financial profile and competitive operating margins as underappreciated strengths. We’ll now explore how Truist’s more optimistic view of Lantheus’s long-term growth...",
      "url": "https://finnhub.io/api/news?id=1da1f419922f321e3eb042cb92a932145e60e5cab3a6dd8333f43a0f45338161"
    }
  }
]